NASDAQ:GBSN - Great Basin Scientific Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume104,097 shs
Average Volume99,205 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Great Basin Scientific, Inc is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious diseases, especially hospital-acquired infections. Its commercially available tests are clostridium difficile (C. diff) and Group B Strep. Its system includes an analyzer and a diagnostic cartridge. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:GBSN
CUSIPN/A
Phone+1-801-9901055

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive GBSN News and Ratings via Email

Sign-up to receive the latest news and ratings for GBSN and its competitors with MarketBeat's FREE daily newsletter.


Great Basin Scientific (NASDAQ:GBSN) Frequently Asked Questions

What is Great Basin Scientific's stock symbol?

Great Basin Scientific trades on the NASDAQ under the ticker symbol "GBSN."

When did Great Basin Scientific's stock split? How did Great Basin Scientific's stock split work?

Great Basin Scientific shares reverse split before market open on Friday, September 16th 2016. The 1-80 reverse split was announced on Wednesday, September 14th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 15th 2016. An investor that had 100 shares of Great Basin Scientific stock prior to the reverse split would have 1 shares after the split.

How were Great Basin Scientific's earnings last quarter?

Great Basin Scientific Inc (NASDAQ:GBSN) posted its quarterly earnings data on Wednesday, March, 22nd. The medical research company reported ($18.25) earnings per share (EPS) for the quarter. The medical research company earned $0.85 million during the quarter. View Great Basin Scientific's Earnings History.

Has Great Basin Scientific been receiving favorable news coverage?

Press coverage about GBSN stock has trended positive this week, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Great Basin Scientific earned a media sentiment score of 2.5 on InfoTrie's scale. They also assigned media stories about the medical research company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the next several days. View News Stories for Great Basin Scientific.

What other stocks do shareholders of Great Basin Scientific own?

Who are Great Basin Scientific's key executives?

Great Basin Scientific's management team includes the folowing people:
  • David Spafford, Executive Chairman of the Board (Age 55)
  • Robert Jenison, Senior Vice President - Research, Chief Technology Officer (Age 50)
  • Ryan Ashton, President, Chief Executive Officer, Director (Age 56)
  • Kirk K. Calhoun, Independent Director (Age 73)
  • Sam Chawla, Independent Director (Age 41)
  • Ronald K. Labrum, Independent Director (Age 60)

What is Great Basin Scientific's official website?

The official website for Great Basin Scientific is http://gbscience.com/.

How can I contact Great Basin Scientific?

Great Basin Scientific's mailing address is 420 E South Temple Ste 520, SALT LAKE CITY, UT 84111-1362, United States. The medical research company can be reached via phone at +1-801-9901055.


MarketBeat Community Rating for Great Basin Scientific (NASDAQ GBSN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  101 (Vote Outperform)
Underperform Votes:  104 (Vote Underperform)
Total Votes:  205
MarketBeat's community ratings are surveys of what our community members think about Great Basin Scientific and other stocks. Vote "Outperform" if you believe GBSN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GBSN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2019 by MarketBeat.com Staff

Featured Article: Marijuana Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel